Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
Recruitment of leukocytes is a characteristic feature of tissue injury in systemic lupus erythematosus, including lupus nephritis. Locally secreted chemokines and their receptors are important mediators of leukocyte recruitment to the specific sites of immune complex injury, and contribute to renal inflammatory disease in the initiation and progression phase. Therefore, chemokines and chemokine receptors represent potential therapeutic targets in lupus nephritis. In this review we summarize available experimental and human data supporting their functional role in lupus nephritis. Moreover, interventional studies with chemokine and chemokine receptor antagonists that show the therapeutic potential of chemokine antagonists in experimental models of lupus nephritis and potentially in human renal disease are discussed.
Vielhauer
Volker
V
Medizinische Poliklinik Innenstadt, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany.
Anders
Hans-Joachim
HJ
Schlöndorff
Detlef
D
D000818:Animals; D002465:Cell Movement; D018925:Chemokines / Q000037:antagonists & inhibitors* / Q000502:physiology; D004195:Disease Models, Animal; D006801:Humans; D007668:Kidney / Q000276:immunology; D007962:Leukocytes / Q000502:physiology; D008181:Lupus Nephritis / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors* / Q000502:physiology
D018925:Chemokines; D019707:Receptors, Chemokine